Table 3 Comparison of tumour HPV DNA, p16 and cyclin D1 status between outcome groups 1 and 2
From: Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer
Total (N=60) | Group 1 (N=39, 65%) | Group 2 (N=21, 35%) | P value | |
|---|---|---|---|---|
HPV-HR | ||||
Positive | 23 (56) | 14 (61) | 9 (50) | 0.54 |
Negative | 18 (44) | 9 (39) | 9 (50) | |
HPV-16/18 | ||||
Positive | 15 (37) | 8 (35) | 7 (39) | 1 |
Negative | 26 (63) | 15 (65) | 11 (61) | |
p16 | ||||
Positive | 27 (66) | 16 (70) | 11 (61) | 0.74 |
Negative | 14 (34) | 7 (30) | 7 (39) | |
Cyclin D1 | ||||
Positive | 12 (29) | 4 (17) | 8 (44) | |
Negative | 29 (71) | 19 (83) | 10 (56) | 0.09 |